These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 37750556)

  • 1. Sustained Increases in Cardiomyocyte Protein
    Ha CM; Bakshi S; Brahma MK; Potter LA; Chang SF; Sun Z; Benavides GA; He L; Umbarkar P; Zou L; Curfman S; Sunny S; Paterson AJ; Rajasekaran NS; Barnes JW; Zhang J; Lal H; Xie M; Darley-Usmar VM; Chatham JC; Wende AR
    J Am Heart Assoc; 2023 Oct; 12(19):e029898. PubMed ID: 37750556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Swim-exercised mice show a decreased level of protein O-GlcNAcylation and expression of O-GlcNAc transferase in heart.
    Belke DD
    J Appl Physiol (1985); 2011 Jul; 111(1):157-62. PubMed ID: 21493720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart.
    Prakoso D; Lim SY; Erickson JR; Wallace RS; Lees JG; Tate M; Kiriazis H; Donner DG; Henstridge DC; Davey JR; Qian H; Deo M; Parry LJ; Davidoff AJ; Gregorevic P; Chatham JC; De Blasio MJ; Ritchie RH
    Cardiovasc Res; 2022 Jan; 118(1):212-225. PubMed ID: 33576380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained
    Tan EP; McGreal SR; Graw S; Tessman R; Koppel SJ; Dhakal P; Zhang Z; Machacek M; Zachara NE; Koestler DC; Peterson KR; Thyfault JP; Swerdlow RH; Krishnamurthy P; DiTacchio L; Apte U; Slawson C
    J Biol Chem; 2017 Sep; 292(36):14940-14962. PubMed ID: 28739801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High glucose induces mitochondrial dysfunction independently of protein O-GlcNAcylation.
    Dassanayaka S; Readnower RD; Salabei JK; Long BW; Aird AL; Zheng YT; Muthusamy S; Facundo HT; Hill BG; Jones SP
    Biochem J; 2015 Apr; 467(1):115-26. PubMed ID: 25627821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excessive
    Umapathi P; Mesubi OO; Banerjee PS; Abrol N; Wang Q; Luczak ED; Wu Y; Granger JM; Wei AC; Reyes Gaido OE; Florea L; Talbot CC; Hart GW; Zachara NE; Anderson ME
    Circulation; 2021 Apr; 143(17):1687-1703. PubMed ID: 33593071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O-GlcNAcylation involvement in high glucose-induced cardiac hypertrophy via ERK1/2 and cyclin D2.
    Ding F; Yu L; Wang M; Xu S; Xia Q; Fu G
    Amino Acids; 2013 Aug; 45(2):339-49. PubMed ID: 23665912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased O-GlcNAcylation induces myocardial hypertrophy.
    Chen X; Zhang L; He H; Sun Y; Shen Q; Shi L
    In Vitro Cell Dev Biol Anim; 2020 Oct; 56(9):735-743. PubMed ID: 32996013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. O-GlcNAc Transferase Promotes Compensated Cardiac Function and Protein Kinase A O-GlcNAcylation During Early and Established Pathological Hypertrophy From Pressure Overload.
    Zhu WZ; El-Nachef D; Yang X; Ledee D; Olson AK
    J Am Heart Assoc; 2019 Jun; 8(11):e011260. PubMed ID: 31131693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excess protein O-GlcNAcylation and the progression of diabetic cardiomyopathy.
    Fricovsky ES; Suarez J; Ihm SH; Scott BT; Suarez-Ramirez JA; Banerjee I; Torres-Gonzalez M; Wang H; Ellrott I; Maya-Ramos L; Villarreal F; Dillmann WH
    Am J Physiol Regul Integr Comp Physiol; 2012 Oct; 303(7):R689-99. PubMed ID: 22874425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of cardiac O-GlcNAcylation: More than just nutrient availability.
    Collins HE; Chatham JC
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165712. PubMed ID: 32014551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased enzymatic O-GlcNAcylation of mitochondrial proteins impairs mitochondrial function in cardiac myocytes exposed to high glucose.
    Hu Y; Suarez J; Fricovsky E; Wang H; Scott BT; Trauger SA; Han W; Hu Y; Oyeleye MO; Dillmann WH
    J Biol Chem; 2009 Jan; 284(1):547-555. PubMed ID: 19004814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiomyocyte Oga haploinsufficiency increases O-GlcNAcylation but hastens ventricular dysfunction following myocardial infarction.
    Dassanayaka S; Brittian KR; Long BW; Higgins LA; Bradley JA; Audam TN; Jurkovic A; Gumpert AM; Harrison LT; Hartyánszky I; Perge P; Merkely B; Radovits T; Hanover JA; Jones SP
    PLoS One; 2020; 15(11):e0242250. PubMed ID: 33253217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein O-GlcNAcylation in cardiovascular diseases.
    Wang HF; Wang YX; Zhou YP; Wei YP; Yan Y; Zhang ZJ; Jing ZC
    Acta Pharmacol Sin; 2023 Jan; 44(1):8-18. PubMed ID: 35817809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting O-GlcNAcylation impacts p38 and Erk1/2 signaling and perturbs cardiomyocyte hypertrophy.
    Papanicolaou KN; Jung J; Ashok D; Zhang W; Modaressanavi A; Avila E; Foster DB; Zachara NE; O'Rourke B
    J Biol Chem; 2023 Mar; 299(3):102907. PubMed ID: 36642184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiomyocyte Ogt is essential for postnatal viability.
    Watson LJ; Long BW; DeMartino AM; Brittian KR; Readnower RD; Brainard RE; Cummins TD; Annamalai L; Hill BG; Jones SP
    Am J Physiol Heart Circ Physiol; 2014 Jan; 306(1):H142-53. PubMed ID: 24186210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiomyocyte Ogt limits ventricular dysfunction in mice following pressure overload without affecting hypertrophy.
    Dassanayaka S; Brainard RE; Watson LJ; Long BW; Brittian KR; DeMartino AM; Aird AL; Gumpert AM; Audam TN; Kilfoil PJ; Muthusamy S; Hamid T; Prabhu SD; Jones SP
    Basic Res Cardiol; 2017 May; 112(3):23. PubMed ID: 28299467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2f1 deletion attenuates infarct-induced ventricular remodeling without affecting O-GlcNAcylation.
    Dassanayaka S; Brittian KR; Jurkovic A; Higgins LA; Audam TN; Long BW; Harrison LT; Militello G; Riggs DW; Chitre MG; Uchida S; Muthusamy S; Gumpert AM; Jones SP
    Basic Res Cardiol; 2019 May; 114(4):28. PubMed ID: 31152247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure.
    Lunde IG; Aronsen JM; Kvaløy H; Qvigstad E; Sjaastad I; Tønnessen T; Christensen G; Grønning-Wang LM; Carlson CR
    Physiol Genomics; 2012 Feb; 44(2):162-72. PubMed ID: 22128088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of
    Chatham JC; Zhang J; Wende AR
    Physiol Rev; 2021 Apr; 101(2):427-493. PubMed ID: 32730113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.